U. Bicker

823 total citations
52 papers, 662 citations indexed

About

U. Bicker is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, U. Bicker has authored 52 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Organic Chemistry and 12 papers in Immunology. Recurrent topics in U. Bicker's work include Immune Cell Function and Interaction (10 papers), Synthesis and Catalytic Reactions (9 papers) and Chemical Synthesis and Analysis (6 papers). U. Bicker is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Synthesis and Catalytic Reactions (9 papers) and Chemical Synthesis and Analysis (6 papers). U. Bicker collaborates with scholars based in Germany, United States and Austria. U. Bicker's co-authors include Willi Fischer, Dieter B. Herrmann, Wolfgang E. Berdel, Michael Fromm, Johann Rastetter, U. Fink, Beate Rinner, D. B. Herrmann, Manfred Heim and K. D. Friedberg and has published in prestigious journals such as Nature, PLoS ONE and Cellular and Molecular Life Sciences.

In The Last Decade

U. Bicker

51 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Bicker Germany 15 286 127 108 99 69 52 662
David A. Ellis United States 16 207 0.7× 146 1.1× 79 0.7× 69 0.7× 55 0.8× 38 580
Mark E. Lesch United States 12 200 0.7× 81 0.6× 64 0.6× 124 1.3× 20 0.3× 17 544
Margaret E. Olson United States 19 384 1.3× 78 0.6× 91 0.8× 55 0.6× 40 0.6× 32 797
Gerald Wolberg United States 16 589 2.1× 100 0.8× 130 1.2× 192 1.9× 33 0.5× 39 1.0k
Kanematsu Sugiura United States 14 254 0.9× 83 0.7× 120 1.1× 35 0.4× 35 0.5× 40 549
Oliver A. Roholt United States 21 756 2.6× 71 0.6× 118 1.1× 168 1.7× 86 1.2× 73 1.2k
T R Tritton United States 15 507 1.8× 50 0.4× 240 2.2× 47 0.5× 49 0.7× 23 905
Eleanor Canova‐Davis United States 21 715 2.5× 46 0.4× 113 1.0× 91 0.9× 91 1.3× 34 1.3k
Esther Martinborough United States 10 416 1.5× 230 1.8× 63 0.6× 316 3.2× 114 1.7× 16 1.1k
Edward Wells United Kingdom 16 246 0.9× 85 0.7× 44 0.4× 111 1.1× 12 0.2× 26 763

Countries citing papers authored by U. Bicker

Since Specialization
Citations

This map shows the geographic impact of U. Bicker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Bicker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Bicker more than expected).

Fields of papers citing papers by U. Bicker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Bicker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Bicker. The network helps show where U. Bicker may publish in the future.

Co-authorship network of co-authors of U. Bicker

This figure shows the co-authorship network connecting the top 25 collaborators of U. Bicker. A scholar is included among the top collaborators of U. Bicker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Bicker. U. Bicker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rinner, Beate, et al.. (2015). Characterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic Analyses. PLoS ONE. 10(8). e0134999–e0134999. 50 indexed citations
2.
Herrmann, Dieter B., et al.. (1990). In vivo antitumour activity of ilmofosine. Cancer Treatment Reviews. 17(2-3). 247–252. 21 indexed citations
3.
Chirigos, Michael A., Michael A. Ussery, J Rankin, et al.. (1990). Antiviral Efficacy of Imexon in the Rauscher Murine Retrovirus Aids Model. Immunopharmacology and Immunotoxicology. 12(1). 1–21. 15 indexed citations
4.
Herrmann, D. B. & U. Bicker. (1990). Drugs in autoimmune diseases.. PubMed. 68 Suppl 21. 15–25. 2 indexed citations
5.
Herrmann, D. B. & U. Bicker. (1988). Ilmofosine (BM 41.440), a new cytotoxic etherphospholipid. Drugs of the Future. 13(6). 543–543. 9 indexed citations
6.
Linn, Thomas, et al.. (1987). Ciamexon in the low dose streptozotocin induced diabetes of mice.. PubMed. 6(3). 113–7. 7 indexed citations
7.
Bicker, U., et al.. (1987). BM 41.440: a new antineoplastic, antimetastatic, and immune-stimulating drug.. PubMed. 1. 361–71. 7 indexed citations
8.
Herrmann, Dieter B., et al.. (1987). Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in rats. Lipids. 22(11). 952–954. 15 indexed citations
9.
Herrmann, Dieter B., et al.. (1987). Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients. Lipids. 22(11). 962–966. 30 indexed citations
10.
Bicker, U., et al.. (1986). Ciamexone, a highly selective immunomodulator — A tool for autoimmune diseases?. Journal of Molecular Medicine. 64(24). 1261–1266. 7 indexed citations
11.
Bicker, U., et al.. (1985). Ciamexone-A New Highly Selective Immunosuppressive Compound. PubMed. 7(1). 127–139. 10 indexed citations
12.
Bicker, U., et al.. (1984). Investigations on the Age-Dependence of T-Lymphocyte Subpopulations and Lymphocyte Reactivity. PubMed. 6(4). 359–377. 2 indexed citations
13.
Fritze, Dieter, et al.. (1983). [Effects of therapy, serology, stage and activity of rheumatoid arthritis on lymphocyte stimulation in whole blood].. PubMed. 42(3). 101–3. 1 indexed citations
14.
Bicker, U., W. Schaumann, & Válerie de Haas. (1983). Optimizing the Lymphocyte Transformation Test in Whole Blood. I. Optimum Conditions for Thymidine Incorporation. PubMed. 5(1-2). 1–12. 4 indexed citations
15.
Modolell, Manuel, et al.. (1981). Immunomodulation by the new synthetic compound BM 12.531,2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone). Experimental Pathology. 19(1). 37–48. 8 indexed citations
16.
Olsson, Lennart & U. Bicker. (1981). Effect of the Immune Modulators BM 12.531 (Azimexone) and BM 41.332 on the Subsets of T-Lymphocytes in Mice. PubMed. 3(3-4). 277–288. 5 indexed citations
17.
Heim, Manfred, et al.. (1981). Influence of oral BM 12531 (INN azimexon) on immune response in untreated cancer patients. Cancer Immunology Immunotherapy. 12(1). 4 indexed citations
18.
Braun, R., et al.. (1981). Influence of the immunomodulating compound BM 12.531 (azimexone) on radioresistance and granulopoietic colony forming units in mice. Experimental Pathology. 20(2). 105–107. 5 indexed citations
19.
Schmitz, Ernst, et al.. (1978). Epaminierungen. II. Herstellung von Aziridinen aus Olefinen und N‐Halogenaminen. Journal für praktische Chemie. 320(3). 413–421. 7 indexed citations
20.
Bicker, U.. (1974). Application of β-D-glucuronides and glucose together suggests a new direction for cancer chemotherapy. Nature. 252(5485). 726–727. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026